Technology

PharmetRx™

A proprietary platform for drug discovery, development, and approval.

PharmetRx™ sharply reduces the time, risks, and cost of drug discovery, preclinical testing, and clinical development by unifying all chemical and biological properties of a compound into a unique molecular fingerprint. Using PharmetRx™ fingerprints, we can repurpose, reformulate, or redesign existing drug molecules to create new and improved medicines.

Sustained Dermal Release™

Our highly stable, non-toxic, high capacity micro-carrier technology.

Sustained Dermal Release™ (SDR™) is a proprietary method for topical application of one or more drugs in combination to the epidermis. The active pharmaceutical ingredient is then released in a controlled manner into the dermal layers. This produces higher levels of the active ingredient in the skin without systemic exposure.

SyntheTx™

Rational design of new lead compounds from proprietary chemical libraries.

This technology is a computationally-driven approach using PharmetRx™ fingerprints to design and synthesize focused de-risked new drug leads. These new compounds are optimized to reduce the liabilities of toxicity and sub-optimal DMPK characteristics. This enables the development of personalized medicines.